{"id":"W3125588754","doi":"10.1007/s13555-021-00487-y","title":"Dupilumab Maintains Long-Term Disease Control in Adults with Moderate-to-Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Windsor Clinical Research","funders":"Sanofi Genzyme; LEO Pharma; Astellas Pharma; Kyowa Hakko Kirin; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Genentech; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Australian Wool Innovation; Amgen; Pfizer; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; Astellas Pharma US","keywords":"Atopic dermatitis; Dupilumab; Medicine; Placebo; Disease; Clinical trial; Randomized controlled trial; Dermatology; Internal medicine; Pediatrics; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002774327,0.0004059612,0.001367818,0.0000737952,0.0002527075,0.00005882172,0.000223576,0.0003929728,0.000247104],"category_scores_gemma":[0.0006027701,0.0002619823,0.0002484713,0.0001806974,0.0003961234,0.000134006,0.00004376856,0.0005564771,0.00007478756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002879882,"about_ca_system_score_gemma":0.0006066887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006084986,"about_ca_topic_score_gemma":0.0003849144,"domain_scores_codex":[0.9959457,0.001450096,0.001041278,0.0007714624,0.0002729772,0.000518469],"domain_scores_gemma":[0.9967134,0.001640447,0.000228156,0.0007535854,0.0001583714,0.0005060285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5515667,0.001452686,0.4222631,0.00004387169,0.0008980833,0.005680504,0.0005543625,0.000004908305,0.00000810885,0.00006977581,0.01434438,0.003113491],"study_design_scores_gemma":[0.4552236,0.0003375767,0.5388868,0.0003203998,0.0002893345,0.0008045326,0.0001297872,0.0004377791,0.00009765446,0.0006740618,0.002464473,0.0003340675],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9507962,0.01375584,0.0001761548,0.03199875,0.0003089179,0.002313955,0.000210503,0.00007625899,0.0003634375],"genre_scores_gemma":[0.9685318,0.003231919,0.00003267823,0.02700206,0.0001068969,0.0003576389,0.0004804805,0.00003527931,0.0002212828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1166237,"threshold_uncertainty_score":0.9999833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01558212892593266,"score_gpt":0.2849635979488684,"score_spread":0.2693814690229357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}